ctrl K

Watchlist Price Alert

Oruka Therapeutics Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

11.16

0.08 (0.72%)

At close: Jun 30, 2025, 3:59 PM

11.21

0.43%

After-hours: Jun 30, 2025, 05:51 PM EDT

Oruka Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	27K	111K	114K	91K	93K
Gross Profit	-27K	-111K	-114K	-91K	-93K
Operating Income	-88.12M	-7.3M	-9.84M	-19.34M	-9.77M
Interest Income	5.86M	1.96M	675K	n/a	n/a
Pretax Income	-83.72M	-5.34M	-9.93M	-19.32M	-9.75M
Net Income	-83.72M	-5.34M	-9.93M	-19.32M	-9.74M
Selling & General & Admin	13.04M	6.17M	5.26M	5.41M	4.68M
Research & Development	75.06M	1.01M	4.46M	13.83M	4.99M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	88.1M	7.18M	9.73M	19.24M	9.67M
Interest Expense	1.47M	n/a	n/a	n/a	9K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	88.12M	7.3M	9.84M	19.34M	9.77M
Income Tax Expense	n/a	n/a	n/a	n/a	-9K
Shares Outstanding (Basic)	16.79M	1.2M	1.2M	1.16M	1.16M
Shares Outstanding (Diluted)	16.79M	1.2M	1.2M	1.16M	1.16M
EPS (Basic)	-4.99	-4.44	-8.27	-16.68	-8.4
EPS (Diluted)	-4.99	-4.44	-8.27	-16.68	-8.4
EBITDA	-82.23M	-5.23M	-9.81M	-19.23M	-9.64M
EBIT	-82.26M	-5.34M	-9.93M	-19.32M	-9.74M
Depreciation & Amortization	27K	111K	114K	91K	93K